Pure Global

“Abbott” XIENCE Sierra Everolimus Eluting Coronary Stent System - Taiwan Registration e7f73c40da53bf817696f01337260362

Access comprehensive regulatory information for “Abbott” XIENCE Sierra Everolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number e7f73c40da53bf817696f01337260362 and manufactured by ABBOTT VASCULAR. The authorized representative in Taiwan is Abbott Medical Taiwan Co..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
e7f73c40da53bf817696f01337260362
Registration Details
Taiwan FDA Registration: e7f73c40da53bf817696f01337260362
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Abbott” XIENCE Sierra Everolimus Eluting Coronary Stent System
TW: “亞培”賽恩錫拉艾諾莉茉斯冠狀動脈塗藥支架系統
Risk Class 3
MD

Registration Details

e7f73c40da53bf817696f01337260362

Ministry of Health Medical Device Import No. 031533

DHA05603153301

Company Information

Ireland

Product Details

For details, it is Chinese approved copy of the imitation order

E Cardiovascular devices

E0001 Cardiovascular stents

Imported from abroad

Dates and Status

Sep 27, 2018

Sep 27, 2028